JNJ-39758979

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for JNJ-39758979, covering 2012-05-14 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate [Phase 2]

See pricing